Literature DB >> 1547830

Poliomyelitis: eradication in sight.

J L Melnick1.   

Abstract

Entities:  

Keywords:  Americas; Asia; Biology; Canada; Delivery Of Health Care; Developed Countries; Developing Countries; Diseases; Europe; Finland; Genetics; Health; Health Services; Immunity; Immunization; Israel; Literature Review; Mediterranean Countries; Netherlands; Neurologic Effects; North America; Northern America; Northern Europe; Physiology; Primary Health Care; Scandinavia; Sweden; United States; Vaccines--beneficial effects; Vaccines--side effects; Viral Diseases--prevention and control; Western Asia; Western Europe

Mesh：

Substances：

Year:  1992        PMID： 1547830      PMCID： PMC2272176          DOI： 10.1017/s0950268800049451

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN： 0950-2688            Impact factor:   2.451


× No keyword cloud information.
  42 in total

1.  Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil.

Authors:  E E da Silva; M A Pallansch; B P Holloway; M J Oliveira; H G Schatzmayr; O M Kew
Journal:  Intervirology       Date:  1991       Impact factor: 1.763

2.  Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines.

Authors:  P L Ogra; H S Faden; R Abraham; L C Duffy; M Sun; P D Minor
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

3.  Advantages and disadvantages of killed and live poliomyelitis vaccines.

Authors:  J L Melnick
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

4.  The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic.

Authors:  G J Schaap; H Bijkerk; R A Coutinho; J G Kapsenberg; A L van Wezel
Journal:  Prog Med Virol       Date:  1984

5.  Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza.

Authors:  E E Lasch; Y Abed; K Abdulla; A G El Tibbi; O Marcus; M El Massri; R Handscher; C B Gerichter; J L Melnick
Journal:  Rev Infect Dis       Date:  1984 May-Jun

6.  Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method.

Authors:  R H Henderson; T Sundaresan
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

7.  Combined use of live and killed vaccines to control poliomyelitis in tropical areas.

Authors:  J L Melnick
Journal:  Dev Biol Stand       Date:  1981

8.  Transgenic mice susceptible to poliovirus.

Authors:  S Koike; C Taya; T Kurata; S Abe; I Ise; H Yonekawa; A Nomoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

9.  Estimation of incidence of poliomyelitis by three survey methods in different regions of the United Republic of Cameroon.

Authors:  D L Heymann; V D Floyd; M Lichnevski; G K Maben; F Mvongo
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

10.  Is poliomyelitis a serious problem in developing countries?--lameness in Ghanaian schools.

Authors:  S Ofosu-Amaah; J H Kratzer; D D Nicholas
Journal:  Br Med J       Date:  1977-04-16
View more
  4 in total

1.  Evaluation of pulse polio and routine immunisation coverage: Alwar District, Rajasthan.

Authors:  J Bhattacharjee; R S Gupta; D C Jain; K K Datta
Journal:  Indian J Pediatr       Date:  1997 Jan-Feb       Impact factor: 1.967

2.  Peptide antisera targeted to a conserved sequence in poliovirus capsid VP1 cross-react widely with members of the genus Enterovirus.

Authors:  T Hovi; M Roivainen
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

Review 3.  Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area.

Authors:  N Goldblum; C B Gerichter; T H Tulchinsky; J L Melnick
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

Review 4.  Interrupting the transmission of wild polioviruses with vaccines: immunological considerations.

Authors:  Y Ghendon; S E Robertson
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.